Envoy Medical (COCH) Invested Capital (2020 - 2026)

Envoy Medical's Invested Capital history runs 7 years deep, the most recent figure standing at $10.2 million for Q1 2026.

• In Q1 2026, Invested Capital rose 141.95% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $10.2 million (up 141.95% YoY), while the FY2025 annual figure was -$12.2 million, up 35.47% from the prior year.
• Invested Capital came in at $10.2 million for Q1 2026 at Envoy Medical, up from -$12.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $10.2 million in Q1 2026 to a low of -$47.5 million in Q1 2023.
• A 5-year average of -$19.0 million and a median of -$18.8 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital sank 1186.14% in 2024 and soared 141.95% in 2026, its largest moves.
• Envoy Medical's Invested Capital stood at -$35.9 million in 2022, then jumped by 95.91% to -$1.5 million in 2023, then tumbled by 1186.14% to -$18.8 million in 2024, then soared by 35.47% to -$12.2 million in 2025, then soared by 183.57% to $10.2 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $10.2 million, -$12.2 million, and -$7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison